Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma

By Prichard Mark   Harris Thomas   Williams Michael E   Densmore John J  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 983-995

Informa Healthcare

Access to resources Recommend Favorite

Lenalidomide offers effective treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Late Effects of Treatment for Hodgkin Lymphoma

By Friedman Debra L.   Constine Louis S.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 3, 2006-03 ,pp. : 249-257

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Rituximab added to CHOP chemotherapy shows promise as a treatment for HIV-associated non-Hodgkin's lymphoma (NHL)

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of High-Dose Chemotherapy with Autologous Stem Cell Support as Initial Treatment of Aggressive Non-Hodgkin's Lymphoma

By Fagnoni Philippe   Milpied Noel  

PharmacoEconomics, Vol. 27, Iss. 1, 2009-01 ,pp. : 55-68

Adis International

Access to resources Recommend Favorite